AMCs can fund unpatentable but valuable innovation

Advance market commitments could address cases where socially beneficial innovation lacks a patent-based incentive — like testing whether mannose (an unpatentable generic sugar) could selectively starve tumors, or developing absent vaccines like Lyme disease — because no actor has the incentive to fund the work despite potential large benefit.